April 27, 2026

味の素グループ・ベンチャーズ、オプトジェネティクス遺伝子治療企業Restore Visionに投資

Other news

January 7, 2026

Ajinomoto Group Ventures year in review

Read more

December 4, 2025

光統合技術を開発するMixx Tech社に出資

Read more

October 23, 2025

Ajinomoto Group Ventures presents cell therapy x AI panel in Boston on Nov 12, 2025

Read more